You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MLYS Sale Disclosure
Rodman David Malcom · SEC Form 4 · Filed Aug 12, 2026
Sale
Calculated transaction value
$58.79K
Rodman David Malcom Chief Medical Officer
MLYS
Transaction date
Aug 10, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed 2 days later
MLYS daily price context
Close on/before transaction
$27.38
Aug 10, 2026
First close after public filing
$26.09
Aug 13, 2026
30-day return after filing
+8.09%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,170 shares @ $27.09
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001933414-26-000118
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$93.51K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Mineralys Therapeutics, Inc. MLYS | Exercise | Aug 10, 2026 | $0 |
| Mineralys Therapeutics, Inc. MLYS Current | Sale | Aug 10, 2026 | $58.79K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Aug 10, 2026 | $34.72K |